Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference

Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) will participate in the SVB Securities Global Biopharma Conference on February 15 at 1:00 p.m. Eastern Time. The company will be represented by Biljana Naumovic, Worldwide Vice President, and Peter Lebowitz, Global Therapeutic Head for Oncology, in a virtual session. Investors can access the live audio webcast on the Johnson & Johnson website. A replay will be available approximately 48 hours after the event.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the SVB Securities Global Biopharma Conference on Wednesday, February 15^th. Biljana Naumovic, Worldwide Vice President, Oncology and Peter Lebowitz, Global Therapeutic Head, Oncology will represent the Company in a virtual session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005064/en/

Investor Contact:

RA-JJCUS-InvestorRel@ITS.JNJ.com

Media Contact:

Jake Sargent (732) 524-1090

Source: Johnson & Johnson

FAQ

When will Johnson & Johnson participate in the SVB Securities Global Biopharma Conference?

Johnson & Johnson will participate on February 15 at 1:00 p.m. Eastern Time.

Who represents Johnson & Johnson at the SVB Securities Global Biopharma Conference?

Biljana Naumovic and Peter Lebowitz will represent Johnson & Johnson during the conference.

How can I access the live audio webcast of Johnson & Johnson's presentation?

The live audio webcast can be accessed on the Johnson & Johnson website at www.investor.jnj.com.

Will there be a replay of Johnson & Johnson's conference presentation?

Yes, a replay of the audio webcast will be available approximately 48 hours after the live event.